Le Lézard
Classified in: Health
Subjects: NPT, LEG, POL, SCZ, AVO

AARP Pennsylvania Statement on Strong Bipartisan U.S. Senate Finance Committee Vote for the Prescription Drug Pricing Reduction Act of 2019


HARRISBURG, Pa., July 26, 2019 /PRNewswire/ -- AARP Pennsylvania State Director Bill Johnston-Walsh issued the following statement today following the U.S. Senate Finance Committee's 19-9 bipartisan vote in favor of the Prescription Drug Pricing Reduction Act of 2019:

"On behalf of our 1.8 million members, AARP Pennsylvania thanks Senator Bob Casey for voting for the Prescription Drug Pricing Reduction Act yesterday in committee. We commend the Senate Finance Committee for its strong bipartisan work to help seniors and all Americans, who pay the highest drug prices in the world.

AARP Pennsylvania is also disappointed in Senator Toomey's vote against the bill. We strongly encourage Senator Toomey to reconsider his 'no' vote as this legislation moves to the Senate floor.

The time is now for legislation to rein in drug prices. The average annual cost of prescription drug treatment increased 57.8% between 2012 and 2017, while the annual income for Pennsylvanians only increased 10.4%. High drug prices disproportionately hurt older Americans, particularly Medicare Part D enrollees who take an average of 4.5 prescription medications each month.

In addition, most Medicare beneficiaries live on fixed incomes, with an average annual income of just over $26,000. At the same time, the average annual price for a single specialty drug used on a chronic basis is now an astounding $79,000. Medications are simply not affordable when their prices exceed a person's annual income. Importantly, the bill voted out of committee yesterday includes an out-of-pocket cap on prescription drugs for seniors in Medicare Part D and cracks down on drugmakers that raise prices higher than the rate of inflation. AARP also supported an amendment offered in committee to allow Medicare to negotiate for lower drug prices, but that amendment was not adopted.

AARP Pennsylvania is deeply committed to winning this fight on behalf of our members and all Americans. We stand with senators who are committed to lowering drug prices and are working to advance this important bill."

About AARP

AARP has 1.8 million members in Pennsylvania. Follow AARP Pennsylvania on Facebook at AARPPA and on Twitter @AARPPA.

AARP is the nation's largest nonprofit, nonpartisan organization dedicated to empowering people 50 and older to choose how they live as they age. With a nationwide presence and nearly 38 million members, AARP strengthens communities and advocates for what matters most to families: health security, financial stability and personal fulfillment. AARP also produces the nation's largest circulation publications: AARP The Magazine and AARP Bulletin. To learn more, visit www.aarp.org or follow @AARP and @AARPadvocates on social media.

CONTACT:

Steve Gardner, AARP PA


(717) 237-6481 or Sgardner@aarp.org


Or


Jacklyn Isasi, AARP PA


(267) 825-9928 or Jisasi@aarp.org

 

SOURCE AARP Pennsylvania


These press releases may also interest you

at 20:12
The food recall warning issued on August 1, 2020 has been updated to include additional distribution information. This additional information was identified during the Canadian Food Inspection Agency's (CFIA) food safety investigation. Industry is...

at 19:16
Today, the U.S. Food and Drug Administration approved Olinvyk (oliceridine), an opioid agonist for the management of moderate to severe acute pain in adults, where the pain is severe enough to require an intravenous opioid and for whom alternative...

at 19:15
The "Syringe and Needle Market - Global Outlook and Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering. The global syringe and needle market is expected to grow at a CAGR of over 10% during the period 2019-2025 The global...

at 19:00
The "US Acne & Rosacea Market: Insights, Trends & Forecast (2020-2024)" report has been added to ResearchAndMarkets.com's offering. The US acne market is expected to reach US$4.49 billion in 2024, recording growth at a CAGR of 4.12% during the period...

at 18:15
The "Coronavirus Disease 2019 (COVID-19) - Analysis of the Emerging Disease Landscape - June 2020" report has been added to ResearchAndMarkets.com's offering. The Epidemiology of COVID-19 is rapidly evolving and a number of companies have begun to...

at 18:10
Service Corporation International (the "Company") announces that the previously announced cash tender offer for any and all of its 5.375% Senior Notes due 2024 (CUSIP No. 817565 CB8/ ISIN No. US817565CB82) (the "Notes"), which expired today at 5:00...



News published on 26 july 2019 at 12:46 and distributed by: